Treating skull base tumors varies depending upon symptoms, tumor growth over time, test results and the potential for post-surgical chemotherapy and radiation. At Atlantic Health System Neuroscience's Skull Base Surgery Program, we take all of these factors into consideration when recommending treatment options – whether it’s medication, traditional surgery or minimally invasive approaches using endoscopy.
Our specialized team, which works in collaboration with Atlantic Neuroscience Institute and the Leonard B. Kahn Head and Neck Cancer Institute, includes experts from neurosurgery, otolaryngology (ear, nose and throat) surgery, neuro-ophthalmology, medical oncology and radiation oncology. As a group, they review each patient’s medical history and decide which treatment method would result in the best long-term outcomes.
Prescription drugs may be used to shrink the size of certain pituitary tumors or treat pain symptoms associated with trigeminal neuralgia. For patients with a cholesteatoma, antibiotics and ear drops may be prescribed to bring infections under control.
Some patients may be candidates for non-invasive stereotactic radiosurgery while others may need either open microsurgery (link to page) or endoscopic surgery (link to page).
After surgery, radiation therapy may be used in the follow-up treatment of tumors that tend to reoccur. Such therapies allow us to continue treating the cancer without causing damage to healthy tissue in the surrounding areas, such as the eyes, optic nerves, brain, brain stem and spinal cord. Our multidisciplinary team of specialists continue to evaluate the patient’s progress at this time.